GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...

"EC approves GSK’s RSV vaccine for adults aged 50-59 years" was originally created and published by Pharmaceutical Technology ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

LONDON, Sept 19 (Reuters) - The EU's drug regulator has approved Bavarian Nordic's (BAVA.CO), opens new tab mpox vaccine for ...

Bronchiolitis alarm in children, there is a life-saving drug but not all Regions can purchase it. The seasonal epidemic of ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna Inc. (NASDAQ: MRNA) made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...

Nursing homes in New York are being urged to protect residents with the updated COVID-19 vaccine. The NYS Department of Health sent letters out to nursing facilities about ...

Moderna plans to cut $1.1bn in costs by 2027, pausing and scrapping several R&D programs. See why I think further downside ...

Delta Air Lines said in an update on Thursday that capacity across the industry was also “moderating” and that its revenue ...